مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,518
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A PRELIMINARY STUDY ON THE EFFECT OF TWO THERAPEUTIC PROCEDURES ON THE EXPRESSION OF BCR-ABL GENE IN CML PATIENTS

Pages

  151-156

Abstract

 Background and Objectives Chronic myelogenesis leukemia (CML) is a chronic myeloproliferative disorder resulting from a specific mutation in a pluripotent stem cell. The association of philadelphia chromosome with this disorder was described in 1973. Subsequently, the BCR-ABL fusion gene and its product which is a tyrosin kinase inhibiting apoptosis were introduced. The treatment of choice for these patients is BMT as well as the new molecular treatment of IMATINIB MESYLATE. The present study was designed in order to compare the rate of expression of the BCR-ABL gene in patients who had undergone treatment by BONE MARROW TRANSPLANTATION with those treated by imatimib.  Materials and Methods Expression of BCR-ABL gene was measured in 34 patients; 17 patients were treated with BMT and 17 with IMATINIB MESYLATE using quantitative PCR on a light cycler instrument.  Results The results obtained in this preliminary study demonstrates that rate of gene expression in patients treated with IMATINIB MESYLATE for more than 8 months was similar to that found in patients treated with BMT who were in relatively stable conditions. Conclusions This finding may be an indication that IMATINIB MESYLATE as a molecular inhibitor can have the same effect as BMT but with less adverse effects. Clearly, definite conclusions require more extensive studies on larger number of patients.  

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    NAVIDI, GH.R., SAMIEI, S., NAGHIZADEH, R., SOLEIMANLO, F., TAHERNIA, R., ESMAEILZADEH, SH., REZVAN, H., & HAJFATH ALI, A.. (2005). A PRELIMINARY STUDY ON THE EFFECT OF TWO THERAPEUTIC PROCEDURES ON THE EXPRESSION OF BCR-ABL GENE IN CML PATIENTS. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), 2(5), 151-156. SID. https://sid.ir/paper/78717/en

    Vancouver: Copy

    NAVIDI GH.R., SAMIEI S., NAGHIZADEH R., SOLEIMANLO F., TAHERNIA R., ESMAEILZADEH SH., REZVAN H., HAJFATH ALI A.. A PRELIMINARY STUDY ON THE EFFECT OF TWO THERAPEUTIC PROCEDURES ON THE EXPRESSION OF BCR-ABL GENE IN CML PATIENTS. THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON)[Internet]. 2005;2(5):151-156. Available from: https://sid.ir/paper/78717/en

    IEEE: Copy

    GH.R. NAVIDI, S. SAMIEI, R. NAGHIZADEH, F. SOLEIMANLO, R. TAHERNIA, SH. ESMAEILZADEH, H. REZVAN, and A. HAJFATH ALI, “A PRELIMINARY STUDY ON THE EFFECT OF TWO THERAPEUTIC PROCEDURES ON THE EXPRESSION OF BCR-ABL GENE IN CML PATIENTS,” THE SCIENTIFIC JOURNAL OF IRANIAN BLOOD TRANSFUSION ORGANIZATION (KHOON), vol. 2, no. 5, pp. 151–156, 2005, [Online]. Available: https://sid.ir/paper/78717/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button